Biodegradation of p-nitrophenol by aerobic granules in a sequencing batch reactor.
In this study, aerobic granules to treat wastewater containing p-nitrophenol (PNP) were successfully developed in a sequencing batch reactor (SBR) using activated sludge as inoculum. A key step was the conditioning of the activated sludge seed to enrich for biomass with improved settleability and higher PNP degradation activity by implementing progressive decreases in settling time and stepwise increases in PNP concentration. The aerobic granules were cultivated at a PNP loading rate of 0.6 kg/ m3 x day, with glucose to boost the growth of PNP-degrading biomass. The granules had a clearly defined shape and appearance, settled significantly faster than activated sludge, and were capable of nearly complete PNP removal. The granules had specific PNP degradation rates that increased with PNP concentration from 0 to 40.1 mg of PNP/L, peaked at 19.3 mg of PNP/(g of VSS) x h (VSS = volatile suspended solids), and declined with further increases in PNP concentration as substrate inhibition effects became significant. Batch incubation experiments show that the PNP-degrading granules could also degrade other phenolic compounds, such as hydroquinone, p-nitrocatechol, phenol, 2,4-dichlorophenol, and 2,6-dichlorophenol. The PNP-degrading granules contained diverse microbial morphotypes, and PNP-degrading bacteria accounted for 49% of the total culturable heterotrophic bacteria. Denaturing gradient gel electrophoresis analysis of 16S rRNA gene fragments showed a gradual temporal shift in microbial community succession as the granules developed from the activated sludge seed. Specific oxygen utilization rates at 100 mg/L PNP were found to increase with the evolution of smaller granules to large granules, suggesting that the granulation process can enhance metabolic efficiency toward biodegradation of PNP. The results in this study demonstrate that it is possible to use aerobic granules for PNP biodegradation and broadens the benefits of using the SBR to target treatment of toxic and recalcitrant organic compounds.